体β-基酸增强了下丘脑的莱普和胰岛素反应能力
Ran Xu1, Nozomi Takahashi1, Kentaro Kaneko1
1Department of Agricultural Chemistry, School of Agriculture, Meiji University, 1-1-1 Higashimita, Tama-ku, Kawasaki-shi 214-8571, Japan.
Nutrients
|February 27, 2026
概括
在肥胖小鼠中,β-HB增强了下丘脑对素和胰岛素的敏感性. 这种体改善了能量恒温,并为新的肥胖干预提供了潜力.
科学领域:
- 代谢信号传递是代谢信号传递.
- 神经内分泌学神经内分泌学
- 肥胖研究的研究.
背景情况:
- 肥胖症涉及下丘脑能量平衡受损,对莱普和胰岛素的反应减少.
- 基体β-基酸盐 (β-HB) 被认为是一种信号代谢物,对下丘脑激素敏感性的影响尚不清楚.
研究的目的:
- 为了研究β-HB对食疗诱导的肥胖小鼠的下丘脑素和胰岛素反应的影响.
- 阐明β-HB对下丘脑功能影响的基础分子机制.
主要方法:
- 在小鼠中,高脂肪饮食 (HFD) 诱导了肥胖,随后是口服或脑内静脉 (ICV) β-HB 给药.
- 评估了厌食激素反应,下丘脑STAT3和Akt信号通路以及基因表达 (炎症,食欲调节).
- 在HFD食小鼠中,慢性ICVβ-HB给药可监测体重和食物摄入量.
主要成果:
- 在肥胖小鼠中,β-HB (口服和ICV) 给药改善了对瘦素和胰岛素的厌氧反应.
- 观察到STAT3 (莱普丁) 和Akt (胰岛素) 的下丘脑酸化增强.
- 发现SOCS3和TNFα的表达减少,POMC的表达增加.
- 慢性ICVβ-HB抑制了HFD养小鼠的体重增加和食物摄入.
结论:
- 在肥胖小鼠中,β-HB的使用增强了下丘脑素和胰岛素敏感性.
- β-HB调节下丘脑的分子环境,减少炎症和改善食欲调节.
- β-HB 作为调节下丘脑功能的信号分子,表明作为抗肥胖干预的潜力.
相关概念视频
Hormones Regulating Blood Glucose
7.5K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.5K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.8K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.8K
Regulation of Food Intake
3.0K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
3.0K
Insulin: The Receptor and Signaling Pathways
5.1K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.1K
Insulin Secretory Vesicles
7.2K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.2K
Glucagon-like Receptor Agonists
1.1K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.1K


